Recombinant human growth hormone (rhGH) has been established as an appropriate treatment to increase the growth rate in children with growth hormone deficiency (GHD), Turner syndrome (TS), Prader-Willi syndrome (PWS), chronic renal failure (CRF), and being born small for gestational age (SGA) [1]. Here, GH1 is linked to Prader-Willi syndrome.